CIK 0001500198
- Non-accelerated filer
- Smaller reporting company
NEUROONE MEDICAL TECHNOLOGIES Corp
Sign in to watch- Ticker
- NMTC
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270863354
- Phone
- +1 952-426-1383
- Business address
- 7599 ANAGRAM DR, EDEN PRAIRIE, MN, 55344
- Former names
- Original Source Entertainment, Inc.
- Open-market buys, last 90 days
- $66,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$66,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-23 | Christianson Mark Business Development Director | Sale | −11,300 | $6.74 | $76K | 1,077,906 |
| 2021-06-02 | MATHIESEN JEFFREY S Director | Grant or award | +4,592 | 36,811 | ||
| 2021-06-02 | MATHIESEN JEFFREY S Director | Grant or award · Option to Purchase Common Stock | +4,682 | 4,682 | ||
| 2021-06-02 | BUCKMAN PAUL Director | Grant or award | +4,592 | 31,424 | ||
| 2021-06-02 | BUCKMAN PAUL Director | Grant or award · Option to Purchase Common Stock | +4,682 | 4,682 | ||
| 2021-06-02 | Andrle Edward Director | Grant or award | +4,592 | 14,404 | ||
| 2021-06-02 | Andrle Edward Director | Grant or award · Option to Purchase Common Stock | +4,682 | 4,682 | ||
| 2021-05-26 | Rosa David A CEO and President | Grant or award · Option to Purchase Common Stock | +83,333 | 416,667 | ||
| 2021-04-26 | Haris Hijaz VP of Marketing | Grant or award · Option to Purchase Common Stock | +60,000 | 60,000 | ||
| 2021-01-27 | McClurg Ronald W. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +140,000 | 140,000 | ||
| 2021-01-27 | Mertens Steve Chief Technology Officer | Grant or award · Option to Purchase Common Stock | +70,000 | 70,000 | ||
| 2021-01-27 | Rosa David A CEO and President | Grant or award · Option to Purchase Common Stock | +1,000,000 | 1,000,000 | ||
| 2021-01-01 | McClurg Ronald W. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +180,000 | 180,000 | ||
| 2020-06-15 | MATHIESEN JEFFREY S Director | Exercise or conversion | +34,020 | $0.04 | $1K | 96,658 |
| 2020-06-15 | MATHIESEN JEFFREY S Director | Exercise or conversion · Option to Purchase Common Stock | −34,020 | 0 | ||
| 2020-06-12 | Christianson Mark VP of Market Development | Sale | −334,000 | $0.60 | $200K | 1,089,206 |
| 2020-06-02 | MATHIESEN JEFFREY S Director | Grant or award | +22,371 | 62,638 | ||
| 2020-06-02 | MATHIESEN JEFFREY S Director | Grant or award · Option to Purchase Common Stock | +23,725 | 23,725 | ||
| 2020-06-02 | BUCKMAN PAUL Director | Grant or award | +22,371 | 80,495 | ||
| 2020-06-02 | BUCKMAN PAUL Director | Grant or award · Option to Purchase Common Stock | +23,725 | 23,725 |
Page 11 of 13 · 243 trades